Phivida Holdings Inc (CSE:VIDA) was featured on Baystreet in an article about the company’s warrant conversion.
The article positioned Phivida as a powerful new entrant to the medical cannabis sector which is capturing the imagination of investors. The author writes “few companies have sprinted from the starting gun harder and faster than Vancouver-based Phivida, offering cannabidiol (“CBD”) infused functional foods, beverages and clinical products.“
The article outlined the warrant conversion and how it’s a good news for shareholders. The author stresses that through the warrant conversion they have an opportunity to maintain their pro-rata position at a lower risk level, by converting and holding.
The article further discussed about the effects of the conversion and states that “the effect of this conversion is a company with about $11 million in cash—effectively doubling Phivida’s position in only 24 trading days.”
The article further talks about the company’s future and ongoing practices in favourable words. “Phivida is rapidly developing CBD infused products under three banners: 1. Organics: professional grade, wholesale whole plant hemp oil extracts; 2. Nutrition: iced tea, vitamin juice and shakes; and 3. Enhanced: tinctures and vitamin shots. In the US, Phivida has already secured a distribution agreement in California and a brand licensing agreement in Oregon with an eye on more agreement to come from Washington and Colorado. Internationally, Phivida recently named Namaste as its preferred global online retailer, initially focused on the German and Australian territories. The company also secured a product distribution agreement with Asayake Inc. to sell its cannabidiol products across Japan. At this pace, and with plenty of fuel in the tank, investors can look forward to more agreements from Phivida in the weeks, months, and years to come,” concluded the author.
Click here to read the complete article
Click here to connect with Phivida Holdings Inc (CSE:VIDA) to receive an Investor Presentation.

Source: www.baystreet.ca


Shareholders with losses exceeding $50,000 are encouraged to contact the firm

The Law Offices of Frank R. Cruz reminds investors of the upcoming December 1, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB ) securities between February 13, 2020 and September 4, 2020 , inclusive (the “Class Period”).

Keep reading... Show less

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the launch of preclinical research studies using psilocybin and N-Acetylcysteine (“NAC”) for the treatment of mild traumatic brain injuryconcussion (“mTBI”) with post-traumatic stress disorder (“PTSD”). The study is in collaboration with a multidisciplinary team of scientists and physicians at the University of Miami Miller School of Medicine under the lead of Michael E. Hoffer, M.D., professor of otolaryngology and neurological surgery.

NAC has been shown to be safe and efficacious in a phase I human clinical study in treating military personnel who had suffered mTBI. The initial research focus is to demonstrate the safety and efficacy of the combination of psilocybin and NAC using broadly accepted rodent models. Final results are expected in 2021. Once this is established, more specific work can examine dose response, medicine uptake, and medicine levels. The research team at the Miller School of Medicine has conducted prior studies involving NAC with mTBI and has a license from the United States Drug Enforcement Administration to conduct research using Schedule I controlled substances, which includes psilocybin.

Keep reading... Show less

Aphria Inc. (” Aphria “, ” we ” or the ” Company “) (TSX: APHA) (NASDAQ: APHA), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, announced it has closed the accretive, strategic acquisition (the ” Acquisition “) of  SW Brewing Company, LLC (” SweetWater Brewing Company ” or ” SweetWater “), one of the largest independent craft brewers in the United States (“U.S.”) based on volume. Beginning with the flagship 420 beverage offerings, SweetWater has created an award-winning lineup of year-round, seasonal and specialty beers, a portfolio of brands closely aligned with a cannabis lifestyle.

Keep reading... Show less
  • Distinguished economist and former CEO of Ecopetrol, Colombia’s largest corporation and the fourth largest Latin America oil and gas producer included in the Fortune Global 500
  • Internationally recognized advocate for the cannabis industry as a driver of change for the Latam economy
  • Adds proven economic and international business experience to boost the global growth of the Khiron business model
  • Company to discuss Q3 2020 financials and host webcast on Tuesday, December 1 st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe announces that Mr. Juan Carlos Echeverry has been appointed to the Board of Directors of the Company, effective immediately. Mr. Echeverry brings extensive corporate, academic and macroeconomic experience, serving as Colombia’s Minister of Finance from 2010 to 2012 and as the CEO and President of Ecopetrol from 2015 to 2017.

Keep reading... Show less

 Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less